Immunohistochemical staining of CD31 revealed that the blood vessel network was well developed in the mock control tumor but appeared to have been inhibited by the MIR452 mimic or siVEGFA (p < 0.05; Figure 6C, the fourth column from the top). This evidence concerns the gene MIR452 and neoplasm.